Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Amateur Traders Corner -- Ignore unavailable to you. Want to Upgrade?

To: Tom Hua who wrote (428)	8/24/2000 3:28:01 PM
From: rogermci®	Read Replies (2) \| Respond to of 19633

Tom...covering MZON in here...I don't trust this market. roger

To: Tom Hua who wrote (428)	8/24/2000 7:02:58 PM
From: Brandon Buttons	Read Replies (1) \| Respond to of 19633

Tom, Just what I was thinking, shooting for 4.50, but will take anything under 5. Still watching ASTM and STEM. I think they will run out of steam about 12:00 tomorrow. They had the CEO on CNBC for ASTM. They were asking the same question as to why his stock was going up. They supply products for the cell companies. I think ASTM will be the one to hit hard. Tom, Do you think this is worth the big jump in the share price after hours. (Up 4 1/8 to 5 5/8) <<Calypte Biomedical Corp. (CALY: news, msgs) shares more than doubled after the company said its HIV-1 antibody urine test has been approved by the State Drug Administration of the People's Republic of China. According to a Calypte statement, its product is now the only urine-based HIV-1 test approved for distribution within China.>> Brandon